Event
MassMEDIC: Medtech Impact Symposium
March 6 @ 9:15 am - 10:00 am EST
The 2025 Symposium will focus on technologies and approaches poised to shape our markets, with the key theme of multidimensional ruggedness and adaptability in the face of uncertainty. We live in changing times — with technological pace, geopolitical risk, and economic pressure converging to create an increasingly intricate path to navigate. Resilience requires insight; and efficiency requires the strength of a deep, diverse community. We invite you to join us at the Symposium to be an active participant in this open discussion.
Join us as Maureen Halligan chairs an exciting panel discussion about
Title: “Targeting 2030: Market Dynamics”
Synopsis: The healthcare delivery landscape is evolving rapidly, compelled by simultaneous forces on multiple fronts. Provider networks are consolidating and facing economic pressures from strained legacy operating models and a rising tide of more financially motivated ownership. Demand continues to escalate as the population grows more numerous, older, and less active. Pervasiveness of technology and data are reshaping the expectations of patients, providers, and payors. Join us as we discuss how these dynamics converge, their potential implications for device manufacturers, and what opportunities and challenges we can expect in 2030.
Panellists:
Chris Coburn, Chief Innovation Officer, Mass General Brigham
Chris Coburn is Chief Innovation Officer of Mass General Brigham, an integrated health care system that includes Harvard University affiliates Brigham and Women’s Hospital, Massachusetts General Hospital, Massachusetts Eye and Ear, and McLean Hospital. Mass General Brigham is the nation’s largest academic research enterprise with over $16 billion in annual revenue, 1.5 million patient visits and more than $2.4 billion in research expenditures. It also has a managed care organization, out-patient facilities and community hospitals. 7,000 of its faculty are appointed at Harvard Medical School.
Antonio Sanchez-Cordero
Antonio Sanchez-Cordero is a global healthcare private equity investor at Archimed, where he specializes in identifying and nurturing strategic investment opportunities in the medical devices and diagnostics sectors. With a robust background in corporate leadership, Antonio has held key roles at leading healthcare multinationals such as Thermo Fisher Scientific, Becton Dickinson and Werfen, focusing on business development, corporate strategy, and M&A.
Matt Chila, Johnson & Johnson, Medtech
Meet our team
Maureen is a people, program and capability leader who unlocks potential, seeks opportunities for impact, and leads delivery of successful medical technology innovations.
当社のラウールはケンブリッジコンサルタンツのグローバル医療機器ビジネスを率いています。当社のチームは、スマートインプラント、外科用ロボットおよび可視化システム、高度な集中治療装置、デジタル手術プラットフォーム、およびデジタルヘルスエコシステムを開発することで、顧客が医療ケアの未来を変革するのを支援しています。
With over 30 years of experience in health and life sciences, Mike is dedicated to improving health outcomes by innovating at the exciting intersection of biology, engineering and advanced computation.
Liz is a program leader who excels at guiding teams of diverse stakeholders through complex system and technology development, including some of Cambridge Consultants’ largest and most complex multidisciplinary development programs.
Brandon engineers the future of healthcare through innovative medical devices. As a technical leader, he navigates unique designs, risk management, system integration, and advanced manufacturing.